Refractory secondary thrombotic microangiopathy with kidney injury associated with systemic lupus erythematosus in a pediatric patient
- 18 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in CEN Case Reports
- Vol. 9 (4), 301-307
- https://doi.org/10.1007/s13730-020-00475-9
Abstract
Thrombotic microangiopathy (TMA) is generally diagnosed through clinical features characterized as microangiopathic hemolytic anemia, thrombocytopenia, and multiple organ injury, as well as by pathological findings such as vascular damage and endothelial cell injury. Rheumatic and autoimmune diseases could be accompanied by secondary TMA; in fact, systemic lupus erythematosus (SLE) is a common disease associated with secondary TMA, and SLE complicated with TMA has been reported to have a poor prognosis. Although TMA occurs rarely in pediatric SLE patients, it often leads to severe clinical conditions. Here, we report a rare case of severe juvenile-onset SLE complicated with TMA and kidney injury. The 5-year-old patient showed renal dysfunction, thrombocytopenia, hemolytic anemia, nephrotic syndrome, hypocomplementemia, and elevation of anti-dsDNA IgG levels. Kidney biopsy revealed mesangial proliferation and endocapillary proliferation, as well as plumped endothelial cells, with full-house pattern deposits in immunofluorescence study. Combination treatment of methylprednisolone pulse therapy followed by oral prednisolone, mycophenolate mofetil, and plasma exchange was effective, whereas eculizumab did not show therapeutic effects. The patient further showed recurrent deterioration, and we initiated intravenous cyclophosphamide in addition to combination treatment and eventually succeeded in controlling the disease. Genome analysis by whole-exome sequencing revealed no particular gene mutation related to either complement disorders or type-1 interferon. Further elucidations concerning the pathogenic mechanisms causing juvenile-onset SLE are needed to establish an efficient treatment strategy for TMA with SLE.Keywords
This publication has 13 references indexed in Scilit:
- Clinical features and prognosis of patients with thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a review of 25 casesItalian Journal of Pediatrics, 2019
- Thrombotic Microangiopathy and the KidneyClinical Journal of the American Society of Nephrology, 2017
- Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic reviewClinical Rheumatology, 2017
- TMA secondary to SLE: rituximab improves overall but not renal survivalClinical Rheumatology, 2017
- Thrombotic microangiopathies: a general approach to diagnosis and managementCMAJ : Canadian Medical Association Journal, 2016
- Plasmapheresis Is Associated With Better Renal Outcomes in Lupus Nephritis Patients With Thrombotic MicroangiopathyMedicine, 2016
- Syndromes of Thrombotic MicroangiopathyThe New England Journal of Medicine, 2014
- A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosusRheumatology, 2009
- Thrombotic MicroangiopathiesThe New England Journal of Medicine, 2002
- Thrombotic microangiopathic hemolytic anemia in systemic lupus erythematosusSeminars in Arthritis and Rheumatism, 1994